Assignee
INDEVUS PHARMACEUTICALS INC
US·13 granted patents·11 pending applications·119 citations·filing 1999–2009
Top patents by PatentIndex Score
24 records- 0195US7452868B2Controlled release formulations of octreotideINDEVUS PHARMACEUTICALS INC·Filed 2006·Granted Nov 18, 2008·64 cites·28 claims
- 0290US7842303B2Long term drug delivery devices with polyurethane based polymers and their manufactureINDEVUS PHARMACEUTICALS INC·Filed 2004·Granted Nov 30, 2010·27 cites·14 claims
- 0379US6974835B2Methods for decreasing cell proliferation based on (3r,4r)-Δ8-tetrahydrocannabinol-11-oic acidsINDEVUS PHARMACEUTICALS INC·Filed 2001·Granted Dec 13, 2005·9 cites·13 claims
- 0478US7057047B2Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2oxo-hexyl)-1-isoidolinoneINDEVUS PHARMACEUTICALS INC·Filed 2005·Granted Jun 6, 2006·4 cites·2 claims
- 0573US6855721B1Methods and compositions for alleviating stutteringINDEVUS PHARMACEUTICALS INC·Filed 2000·Granted Feb 15, 2005·5 cites·1 claims
- 0669US6914072B2Cannabinoid drugsINDEVUS PHARMACEUTICALS INC·Filed 2001·Granted Jul 5, 2005·3 cites·15 claims
- 0768US7553847B2Use of pagoclone for the treatment of social anxiety disorderINDEVUS PHARMACEUTICALS INC·Filed 2006·Granted Jun 30, 2009·2 cites·3 claims
- 0864US6949653B2Methods for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinoneINDEVUS PHARMACEUTICALS INC·Filed 2003·Granted Sep 27, 2005·2 cites·1 claims
- 0964US2005158287A1Methods for using the obese gene and its gene product to identify hematopoietic progenitor cellsINDEVUS PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 1061US7026332B2Methods of treating obsessive-compulsive disorderINDEVUS PHARMACEUTICALS INC·Filed 2002·Granted Apr 11, 2006·3 cites·3 claims
- 1161US6953670B2Methods for identifying compounds capable of supplementing the biological activity of leptinINDEVUS PHARMACEUTICALS INC·Filed 2002·Granted Oct 11, 2005·0 cites·11 claims
- 1261US2009208540A1Implantable device for the delivery of naltrexone and methods of use thereofINDEVUS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1359US6838079B2Methods for using the obese product to stimulate hematopoietic developmentINDEVUS PHARMACEUTICALS INC·Filed 2002·Granted Jan 4, 2005·0 cites·11 claims
- 1458US2009214634A1Compositions and methods for the treatment of bladder cancerINDEVUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1556US7304158B2Method for making 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone)INDEVUS PHARMACEUTICALS INC·Filed 2006·Granted Dec 4, 2007·0 cites·5 claims
- 1654US2005266486A1Methods for treating obesity by inhibiting expression of obese gene product receptor variantINDEVUS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1751US2007093519A1Anti-emetic uses of cannabinoid analogsINDEVUS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1851US2007099988A1Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acidsINDEVUS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1949US2008182892A1Treatment of interstitial cystitis using (6aR, 10aR)-delta-8-tetrahydrocannabinol-11-oic acidsINDEVUS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2046US2005232983A1Transdermal patchINDEVUS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2144US2006128794A1Treatment of interstitial cystitis using (6aR,10aR)-delta8-tetrahydrocannabinol-11-OIC acidsINDEVUS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2242US2006217405A1Interstitial cystitis treatmentINDEVUS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2341US2006128738A1Treatment of interstitial cystitis using cannabinoid analogsINDEVUS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2435US6524806B1Methods of screening for ligands of human hemetopoietin receptor HU-B1.219INDEVUS PHARMACEUTICALS INC·Filed 1999·Granted Feb 25, 2003·0 cites·77 claims
Join the waitlist — get patent alerts
Get an alert when INDEVUS PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →